FILE:ALXN/ALXN-8K-20070807120624.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( General Instruction A.2. below):
see
 
 
 
 
 
On August 1, 2007, the Board of Directors of Alexion Pharmaceuticals, Inc. designated Scott Phillips, 30, as its principal accounting officer. Mr. Phillips has served as Alexion's Corporate Controller and Chief Accounting Officer since April 30, 2007, when he joined the Company. Between November 2000 and April 2007, Mr. Phillips was employed by PricewaterhouseCoopers LLP, an independent public accounting firm, most recently as a senior manager in the technology audit practice, during which time Mr. Phillips managed the audits of both public and private corporations in the software, manufacturing and biotechnology sectors. Prior to PricewaterhouseCoopers, Mr. Phillips was employed by Ernst & Young LLP.
Prior to the designation of Mr. Phillips, the responsibilities of principal accounting officer were held by Vikas Sinha, Alexion's Senior Vice President and Chief Financial Officer. Mr. Sinha continues to serve as Alexion's Chief Financial Officer and principal financial officer.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


